Taylor C R
J Pathol. 1976 Apr;118(4):201-19. doi: 10.1002/path.1711180403.
Detailed observations were made of the development of "reticulum cell sarcoma" in four strains of laboratory mice: SJL/J, NZB, PBA and (BALB/C X A)F1 hybrids injected with parental (BALB/C) spleen cells. Morphological evidence of a florid B cell immune response was present in all four strains, and was succeeded by a phase of atypical lymphoid hyperplasia, prior to the appearance of malignant neoplasms in lymph-nodes or spleen. These neoplasms correspond to descriptions of "reticulum cell sarcoma" of the mouse. The demonstration, by immunoperoxidase methods, of immunoglobulin within a proportion of these "malignant reticulum cells" reinforces the opinion, based on the morphological evidence of hyperplasia progressing to neoplasia, that the "reticulum cell sarcoma" of the mouse is B lymphocyte derived.
对四株实验小鼠(SJL/J、NZB、PBA以及注射了亲代(BALB/C)脾细胞的(BALB/C×A)F1杂种小鼠)的“网状细胞肉瘤”发展过程进行了详细观察。在所有四株小鼠中均出现了活跃的B细胞免疫反应的形态学证据,在淋巴结或脾脏中出现恶性肿瘤之前,接着是一个非典型淋巴样增生阶段。这些肿瘤与小鼠“网状细胞肉瘤”的描述相符。通过免疫过氧化物酶方法在部分这些“恶性网状细胞”中证明免疫球蛋白,这进一步支持了基于增生发展为肿瘤的形态学证据得出的观点,即小鼠的“网状细胞肉瘤”源自B淋巴细胞。